Pharmacokinetics of recombinant human annexin A5 (SY-005) in patients with severe COVID-19Brent J. Tschirhart, Qingping Feng, Marat Slessarev et al.|Frontiers in Pharmacology|2024Cited by 6
Annexin A5 in Patients With Severe COVID-19 Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Feasibility TrialClaudio M. Martin, Qingping Feng, Marat Slessarev et al.|Critical Care Explorations|2023Cited by 5